首页> 外文期刊>International braz j urol >Editorial Comment: Adjuvant Single-Dose Upper Urinary Tract Instillation of Mitomycin C After Therapeutic Ureteroscopy for Upper Tract Urothelial Carcinoma: A Single-Centre Prospective Non-Randomized Trial
【24h】

Editorial Comment: Adjuvant Single-Dose Upper Urinary Tract Instillation of Mitomycin C After Therapeutic Ureteroscopy for Upper Tract Urothelial Carcinoma: A Single-Centre Prospective Non-Randomized Trial

机译:编辑评论:辅助单剂量上尿道丝霉素C的辅助尿素CIN尿路上皮癌治疗尿路上皮癌:单中心前瞻性非随机试验

获取原文
           

摘要

This article aims to demonstrate the efficacy of mitomycin C infusion right after the ureteroscopyprocedure for ablation of urothelial carcinomas in patients submitted to kidney preservation protocol.Fifty-two patients were enrolled from April 1, 2015 to August 31, 2018, submitted to laser ablation followed by a single dose of mitomycin- (ASDM).The study was approved by the ethics committee. All patients with urothelial lesion T2 andthose in which endoscopic resection seemed to be feasible were included. Patients with bladder lesionsgreater than 3.0 cm or incomplete ablation of the upper urinary tract were excluded. The control groupwas composed of patients with mitomycin C intolerance but with similar radiological aspects.
机译:本文旨在证明丝霉素C输注在提交给肾脏保存方案的患者中的尿液癌中烧蚀后丝霉素C输注。从2015年4月1日至2018年4月31日开始,提交激光消融术后,从2015年4月1日开始举行尿路癌泌尿情况通过单一剂量的丝霉素 - (ASDM)。该研究得到了伦理委员会的批准。所有尿路上位病变的患者均包括其中内镜切除似乎是可行的。排除了膀胱LesionsGreater比3.0cm或不完全消融的膀胱内脏的患者被排除在外。对照组由丝霉素C不耐受患者组成,但具有相似的放射性方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号